Health
Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination – News-Medical.Net
New research from a team of scientists in Australia finds that the second ‘booster’ dose of the Pfizer-BioNTech vaccine did not increase vaccine efficacy against…
New research from a team of scientists in Australia suggests that the second ‘booster’ dose of the Pfizer-BioNTech vaccine may not increase vaccine efficacy against severe acute respiratory syndrome (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19).
The results suggest one dose of the vaccine could be sufficient in providing a robust immune response 11 days after inoculation.
The findings could help shape policy as vaccine rollout has been slow in countries such as the United…
-
Business20 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News19 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General14 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News16 hours agoTips to improve engagement – Proctor